Novartis (NOVN) shares rose after second quarter results exceeded expectations. Core earnings and revenue both beat forecasts. The pharmaceutical company also reaffirmed its full year guidance and medium term outlook.
Join our Mailing list!
Sign up to get all the latest financial news and business updates.
Please fill in the form and we will get in touch with you shortly and help answer any questions you may have about Offshore Supporting services.
